Cargando…
Management of lymphangioleiomyomatosis
Lymphangioleiomyomatosis (LAM), a multisystem disease affecting almost exclusively women, is characterized by cystic lung destruction and presents with dyspnea, recurrent pneumothoraxes, chylous effusions, lymphangioleiomyomas, and angiomyolipomas. It is caused by the proliferation of a cancer-like...
Autores principales: | Taveira-DaSilva, Angelo M., Moss, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251421/ https://www.ncbi.nlm.nih.gov/pubmed/25580270 http://dx.doi.org/10.12703/P6-116 |
Ejemplares similares
-
Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2015) -
Therapeutic options for lymphangioleiomyomatosis (LAM): where we are and where we are going
por: Taveira-DaSilva, Angelo M, et al.
Publicado: (2009) -
Computer grading of lung disease severity in patients with lymphangioleiomyomatosis referred for transplantation
por: Taveira-DaSilva, Angelo M., et al.
Publicado: (2022) -
Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis
por: Matthew, Brianna P., et al.
Publicado: (2021) -
Recent advances in the management of lymphangioleiomyomatosis
por: Xu, Kai-Feng, et al.
Publicado: (2018)